Unknown NA INTERVENTIONAL 2-arm NCT03045692

Assessment of Kidney Function for Drug Dosage Adjustments in Critically Ill Patients

Reliable Methods to Assess Kidney Function for Drug Dosage Adjustments in Critically Ill Patients - Comparison of Timed Clearance of Creatinine and Creatinine Based Estimated GFR

Sponsor: Samsung Medical Center

Conditions ICU Patients

Interventions kidney function assessment by 4 hour creatinine clearance kidney function assessment by creatinine based eGFR

Updated 6 times since 2017 Last updated: Feb 6, 2017 Started: Feb 13, 2017 Primary completion: Feb 28, 2019 Completion: Apr 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03045692, this NA trial focuses on ICU Patients and remains ongoing. Sponsored by Samsung Medical Center, it has been updated 6 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Jun 2019 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Feb 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Samsung Medical Center

Data source: Samsung Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.